We have previously demonstrated, by using a detergent-solubilized system, the existence of specific diphtheria toxin-binding glycoproteins on the surface of toxin-sensitive cells. We have now tested the effect of tunicamycin treatment on the sensitivity of cells in culture to diphtheria toxin and have investigated the toxin sensitivity of mutant cells with known defects in glycosylation of asparagine-linked glycoproteins. Treatment of CHO-Kl cells with tunicamycin, which blocks the synthesis of both high-mannose-type and complex-type oligosaccharide chains of asparagine-linked glycoproteins, resulted in a 50-to 100-fold decrease in sensitivity to diphtheria toxin. In contrast, CHO-Kl mutants, defective in the synthesis of either high-mannose-type or complex-type oligosaccharides, showed no difference in toxin sensitivity compared with that of their parental cell lines. When we used an acid shock system, which is believed to result in receptor-dependent direct toxin penetration at the cell surface, the toxin sensitivity of tunicamycin-treated cells was not restored to that of untreated cells, suggesting that tunicamycin treatment results in a decrease in functional toxin receptors. Direct binding studies with 125I-labeled toxin demonstrated that this decrease in functional receptors is due to a decrease in the affinity of the receptors rather than to a change in the number of receptors. Taken together, these data are consistent with the interpretation that the diphtheria toxin receptor is a glycoprotein and suggest that the toxin binds neither to carbohydrate residues unique to the high-mannose-type oligosaccharides nor to those unique to the complex-type oligosaccharides. Furthermore, these data are consistent with the hypothesis that diphtheria toxin binds to the peptide backbone of the glycoprotein receptor.
We have previously demonstrated, by using a detergent-solubilized system, the existence of specific diphtheria toxin-binding glycoproteins on the surface of toxin-sensitive cells. We have now tested the effect of tunicamycin treatment on the sensitivity of cells in culture to diphtheria toxin and have investigated the toxin sensitivity of mutant cells with known defects in glycosylation of asparagine-linked glycoproteins. Treatment of CHO-Kl cells with tunicamycin, which blocks the synthesis of both high-mannose-type and complex-type oligosaccharide chains of asparagine-linked glycoproteins, resulted in a 50-to 100-fold decrease in sensitivity to diphtheria toxin. In contrast, CHO-Kl mutants, defective in the synthesis of either high-mannose-type or complex-type oligosaccharides, showed no difference in toxin sensitivity compared with that of their parental cell lines. When we used an acid shock system, which is believed to result in receptor-dependent direct toxin penetration at the cell surface, the toxin sensitivity of tunicamycin-treated cells was not restored to that of untreated cells, suggesting that tunicamycin treatment results in a decrease in functional toxin receptors. Direct binding studies with 125I-labeled toxin demonstrated that this decrease in functional receptors is due to a decrease in the affinity of the receptors rather than to a change in the number of receptors. Taken together, these data are consistent with the interpretation that the diphtheria toxin receptor is a glycoprotein and suggest that the toxin binds neither to carbohydrate residues unique to the high-mannose-type oligosaccharides nor to those unique to the complex-type oligosaccharides. Furthermore, these data are consistent with the hypothesis that diphtheria toxin binds to the peptide backbone of the glycoprotein receptor.
Diphtheria toxin (DT) is synthesized as a single polypeptide chain (molecular weight, 58,342) with two disulfide bridges and no free sulfhydryl groups. Limited proteolysis yields an amino-terminal fragment, the A fragment (molecular weight, 21,167), and a carboxy-terminal fragment, the B fragment (molecular weight, 37, 195) , which remain associated by an interchain disulfide bond (1, 2, 26) . The A fragment inhibits protein synthesis through the NADdependent ADP ribosylation of elongation factor 2 present in the cytosol of eucaryotic cells (2, 26) . The B fragment is responsible for interaction of the toxin with specific receptors on toxin-sensitive cells (23, 47) . It is widely held that the DT receptor possesses a protein component, since treatment of toxin-sensitive cells with such proteases as trypsin, pronase (21, 24) , or bromelain (K. Hranitzky, D. A. Hart, and L. Eidels, Fed. Proc. 43:1956, 1984 ; manuscript in preparation) results in a significant decrease in sensitivity to the toxin. In contrast, treatment of toxin-sensitive cells with neuraminidase has been reported to result in a slight increase in sensitivity to DT (21, 35) , suggesting that carbohydrate structures that become exposed on removal of sialic acid residues may be involved in DT binding. Interestingly, neuraminidase-sensitive oligosaccharides are present in both gangliosides and glycoproteins; gangliosides, however, appear not to be receptors for DT since they do not prevent intoxication of cells by DT (26) .
In our laboratory, specific DT-binding cell surface glycoproteins from guinea pig lymph node cells (30) , hamster lymph node and thymus cells (27) , and more recently from monkey kidney Vero cells and Chinese hamster ovary (CHO-Kl) cells (C. P. Robles, D. A. Hart, and L. Eidels, Fed. Proc. 42:1809, 1983 ; manuscript in preparation) have been identified and characterized. It has been suggested that these DT-binding cell surface glycoproteins are likely candidates for the DT receptor (27) (28) (29) (30) . These glycoproteins have a high molecular weight (ca. 150,000 and 70,000) and show anomalous behavior on sodium dodecyl sulfate-polyacrylamide gel electrophoresis, indicating the presence of a significant degree of carbohydrate (27) . The binding of DT to these cell surface glycoproteins has been shown to be specific for the B fragment of the toxin (27, 28, 30) . This binding is inhibited by nucleotides, polyphosphates, and polycations (28, 29) , compounds which are known to protect cells by interfering with toxin-receptor interactions (8, 22) . The binding is saturable with respect to both toxin and receptor (27, 30) (40) , and they lack the enzyme UDP-N-acetylglucosamine glycoprotein N-acetylglucosaminyltransferase (25, 41 leucine and incubated for 18 h at 37°C. The cells were washed twice with MPBS and solubilized in 0.1 ml of a solution containing 0.05% sodium dodecyl sulfate, 0.5 mg of DNase I per ml, 1 mM CaCl2, and 1 mM MgCl2. A 0.02-ml portion of the solubilized cells was spotted onto a strip of Whatman 3MM paper, which was then soaked in 10% trichloroacetic acid (TCA) for 30 min, washed twice with 95% ethanol, dried, and assayed for radioactivity by counting with 5 ml of toluene-Liquifluor in an LS-350 liquid scintillation counter (Beckman Instruments, Inc., Fullerton, Calif.). All assays were performed in triplicate, and the symbols in the figures represent the average of these triplicates. The variation from the mean was not greater than 10%. The concentration of toxin that inhibits protein synthesis to 50% of the control value of nonintoxicated cells is referred to as ID50.
Cytotoxicity assay. The cytotoxic effect of DT on cultured cells was assayed by quantitating the inhibition of protein synthesis as measured by the cellular incorporation of [3H]leucine into TCA-insoluble material. The assay used was a modification of that described by Draper et al. (6) . At 24 h before an experiment, tunicamycin-treated, swainsonine-treated, or untreated cells were seeded in 24-well tissue culture plates at 105 cells per well in 1.0 ml of MEMEAM supplemented with 10% FBS, nonessential amino acids, and penicillin-streptomycin. Immediately before the assay, the medium was removed, the cells were washed with MPBS, and 1 ml of medium with tunicamycin, swainsonine, or no agent included was added to each well. DT, diluted in medium, was then added to yield a final concentration of 10-2 to 10-8 mg/ml per well. After incubation for 2 h at 37°C, the medium containing unbound toxin was removed, the cells were washed twice with MPBS, and 1 ml of deficient Dulbecco modified Eagle medium (DDMEM) (Irvine Scientific) with 10% FBS and 2 ,uCi of [3H]leucine was added to each well. After incubation for 18 h at 37°C, the cells were washed twice with MPBS and assayed for TCA-precipitable radioactivity as described above.
Receptor-dependent acid shock system. Toxin binding receptors were detected by using a receptor-dependent acid shock system described by Sandvig and Olsnes (33, 34) and Draper and Simon (7). Briefly, CHO-Kl cells grown with or without tunicamycin in MEMEAM were exposed to DT for 2 h at 37°C in the presence or absence of 10 mM ammonium chloride. The medium containing the toxin was removed, and the cells were rinsed twice with MPBS supplemented with 10 mM ammonium chloride. The cells were then acid shocked with medium containing 10 mM ammonium chloride and 20 mM HEPES-hydrochloride (pH 4.5) or mock acid shocked with medium containing 10 mM ammonium chloride and 20 mM HEPES (pH 7.2). After incubation for 10 min at 37°C, the cells were rinsed twice with MPBS, and 1 ml of DDMEM with 10% FBS, 2 ,uCi of [3H]leucine, and 10 mM ammonium chloride was added to each well. After incuba- tion for 18 h at 37°C, the cells were assayed for TCAprecipitable radioactivity as described above.
Radiolabeling of DT. DT was labeled by using a modification of the lodogen method originally described by Fraker and Speck (12) . Briefly, a 0.1-mi portion of a chloroform solution containing 100 ,ug of Iodogen was placed in a glass test tube (10 by 75 mm). The chloroform was evaporated by incubating the tube in a fume hood so that a thin film of Iodogen formed in the bottom. To another tube were added 100 ,ug of DT, 10 ,ug of sodium iodide, and 1 mCi of carrier-free sodium [1251] iodide (all in PBS). The final volume of this mixture was adjusted to 125 ,ul with PBS and chilled on ice. The reaction was initiated by pipetting the toxin solution into the tube containing the Iodogen. After 5 min at 4°C, the mixture was centrifuged (5 min at 1,500 x g) through Sephadex G50 preequilibrated with PBS containing 100 ,ug of gelatin per ml to remove the unbound iodine. The toxin radioiodinated by this procedure was 90 to 95% TCA precipitable with a specific radioactivity of approximately 107 cpm/lLg.
Binding of radiolabeled DT. Cells that had been seeded 18 h earlier (at 105 cells per ml for both Vero and CHO-Kl cells) with or without tunicamycin in 24-well tissue culture plates and incubated at 370C were rinsed with PBS, and 1 ml of fresh serum-free medium (M199 medium supplemented with 50 jig of bovine serum albumin fraction V per ml, 100 ,ug of gelatin per ml, and 20 mM HEPES [pH 7.3]) was added to each well. Either iodinated toxin or iodinated toxin plus a 50-fold excess (100-fold for CHO-Kl cells) of unlabeled toxin was added to the wells, and incubation was carried out for 4 h at 4°C for Vero cells or for 4 h at 37°C in the presence of 20 mM methylamine for CHO-Kl cells. Each monolayer was rinsed four times with M199 serum-free medium, dissolved in 1.0 ml of 0.1 M NaOH, and counted in a model 1197 Tracor analytic automatic gamma counter. All assays were carried out in triplicate; the variation from the mean was 5 to 10%.
RESULTS
Effect of tunicamycin and swainsonine on the sensitivity of cells to DT. To investigate the possible glycoprotein nature of the DT receptor and the possible role of carbohydrates in toxin binding, CHO-Kl cells were grown in the presence of tunicamycin or swainsonine. Tunicamycin inhibits the glycosylation of proteins by blocking the first step in the biosynthetic pathway of the oligosaccharide portion of asparagine-linked high-mannose-and complex-type glycoproteins (43, 44) . CHO-Kl cells grown in the presence of tunicamycin (0.55 ,ug/ml for 96 h) were 50-to 100-fold less sensitive to intoxication than were untreated cells (Fig. 1) . In preliminary experiments it was determined that under these conditions (in the absence of DT), protein synthesis was inhibited by 20% cotmpared with that for untreated cells, whereas incorporation of radiolabeled glucosamine and mannose was inhibited by 67 and 73%, respectively. Qualitatively similar results were found with Vero cells grown in the presence of tunicamycin. We found that tunicamycin was much more toxic for Vero cells than for CHO-Kl cells, and accordingly the cells were grown in the presence of a decreased amount of tunicamycin (0.1 ,ug/mi). Under these conditions, protein synthesis was inhibited by 21%, glucosamine incorporation was inhibited by 40%, and mannose incorporation was inhibited by 51%. Vero cells grown in the presence of this lower tunicamycin concentration were still 10-fold less sensitive to DT than were untreated cells (data not shown). (39, 40) .
Such lectin resistance has been shown to be correlated with the lack of lectin-specific carbohydrate structures on the cell surface (15) . If resistance not only to wheat germ agglutinin but also to other lectins including phytohemagglutinin, ricin, and Lens culinaris agglutinin (40) . This pleiotropic lectin resistance is due to the loss of the enzyme UDP-N-acetylglucosamine-glycoprotein N-acetylglucosaminyltransferase (GlcNAc-T1) (EC 2.4.1.51) (25, 41) . The absence of GlcNAc-T1 precludes the addition of GlcNAc to mannose acceptors linked oa-1,3 at the level of (Man)5(GlcNAc)2-Asnprotein and the subsequent addition of galactose, sialic acid, and fucose residues, resulting in a lack of both hybrid and complex-type glycoproteins and in an increase of high-mannose-type glycoproteins (15) . A second mutant cell line, B211, described by Krag et al. (16) (17) (18) , is resistant to concanavalin A and is unable to transfer glucose from glucosylphosphoryldolichol to the lipid-bound growing oligosaccharide chain (16) , resulting in an absence of highmannose-type glycoproteins (18) . A third CHO-Kl cell mutant, B4-2-1, was also tested for its sensitivity to toxin. The cell line B4-2-1, described by Robbins et al. (32, 42) , was selected for resistance to mannose 6-phosphate-ricin conjugates and was shown to be unable to synthesize mannosylphosphoryldolichol, resulting in an absence of normal high-mannose-type oligosaccharides on mature glycoproteins. Both the B211 and B4-2-1 cell lines have been shown to synthesize complex-type oligosaccharides (18, 42) .
The sensitivities of these mutants and their parental cell lines toward diphtheria toxin are compared in Table 1 . The ID50 of DT for WgaR (9.0 x 10-6 mg/ml) was only 1.4-fold greater than that of the wild-type parental line Pro-5 (6.6 x 10-6 mg/ml). This result indicates that such carbohydrate residues as sialic acid, galactose, and fucose, which are unique to the complex-type oligosaccharides, do not play a role in the binding or internalization of DT. The mutant cell line B211 exhibited sensitivity to toxin equal to that of its parental line WTB (ID50, 6.5 x 10-6 and 6.6 x 10-6 mg/ml, respectively). Similarly, the third mutant, B4-2-1, was as sensitive to DT as was its parent N211-1-8 (1.1 x 1i-0 versus 1.2 x 10-5 mg/ml). These results with the B211 and B4-2-1 cell lines suggest that the high-mannose-type oligosaccharides are also not involved in binding or internalization of DT. Taken together, the results with these mutants suggest that either the toxin binds to carbohydrate moieties that are common (internal GlcNAc or mannose residues) to the complex-and high-mannose-type glycoproteins or the toxin binds to the peptide backbone of the receptor.
Acid shock receptor-dependent penetration of DT. Under conditions in which the culture medium is acidified to pH 4.5, conditions which mimic the low-pH environment of endocytic vesicles, it has been suggested that DT penetrates directly through the plasma membrane into the cytosol of the cell (7, 33, 34) . This receptor-dependent penetration of DT has been shown to bypass the protective effect of such lysosomotropic amines as ammonium chloride and chloroquine (4, 5, 7, 14, 19, 33) and should serve as a test system for determining whether the protective effect seen with tunicamycin-treated cells is due to a decrease in functional toxin receptors or to a defect in a subsequent step in the internalization of the toxin. If there is a decrease in functional receptors present on the cell surface oftunicamycintreated cells, then acid shocking of these treated cells should still result in a decreased sensitivity to DT compared with that of untreated acid shocked cells. However, if tunicamycin has no effect on functional toxin receptors and the effect of the drug is at a subsequent step in the internalization process, then there should be no difference in sensitivity to DT between acid shocked tunicamycin-treated and untreated cells. Figure 2A shows that untreated CHO-Kl cells that were incubated with toxin for 2 h at 37°C in the presence of 10 mM ammonium chloride at pH 7.2 were protected against intoxication. Cells incubated in the presence of DT for 2 h at 37°C without ammonium chloride at pH 7.2 had an ID50 of 4 x 106 mg/ml. Similarly, cells incubated in the presence of toxin for 2 h at 37°C with 10 mM ammonium chloride at pH 7.2 and then acid shocked at pH 4.5 had an ID50 of 1.2 x 10-5 mg/ml. This miinimal difference in ID50 values between the curves in Fig. 2A confirms that toxin molecules bound to toxin-specific receptors can be directed into the cytosol via the acid shock procedure and suggests that this technique is a reasonable measure of functional toxin receptors present. Figure 2B shows that when tunicamycin-treated cells were acid shocked, the ID50 was 1.6 x 10-4 mg/ml. Interestingly, this value is not significantly different from that obtained for tunicamycin-treated non-acid shocked cells (ID50, 1.2 x 10-4 mg/ml), and more importantly, this value still is approximately 15-fold greater than the values obtained for the untreated acid-shocked cells (Fig. 2A) . These results suggest that the protective effect mediated.by tunicamycin is due to a decrease in functional toxin-binding receptors, not to a defective toxin entry process.
The above results are not unique to CHO-Kl cells. Acid shock treatment of tunicamycin-treated Vero cells also did not result in restoration of toxin sensitivity to the level observed with untreated control cells (data not shown).
Binding of radiolabeled DT to tunicamycin-treated cells. It was possible that the decrease in functional toxin receptors as a result of tunicamycin treatment was due either to an actual decrease in toxin-binding capacity or to an inability of receptor-bound toxin to be acid shocked into the treated cells. Therefore, to distinguish between these two possibilities we investigated the specific association of radiolabeled DT with tunicamycin-treated and untreated cells. Two types of studies were performed.
First, owing to the difficulty of demonstrating specific binding of radioiodinated DT to CHO-Kl cells (23) , the alternative method of Mekada et al. radioiodinated DT by tunicamycin-treated and untreated CHO-Kl cells. With this method, the association of radiolabeled toxin is measured at 37°C in the presence of 20 mM methylamine, which prevents degradation of the internalized toxin (20) . The level of specific association (total association minus the nonspecific association that occurred in the presence of 100-fold excess unlabeled toxin) was determined to be 51% for untreated CHO-Kl cells, whereas tunicamycintreated cells had a level of specific association of only 20%. Control untreated Vero cells and tunicamycin-treated Vero cells demonstrated a specific association of 91 and 3%, respectively. The results obtained with both types of untreated cells are in agreement with those of Mekada et al. (20) , who found a lower specific association for CHO-Kl cells (56%) compared with that for Vero cells (98%).
Second, we measured specific binding of radiolabeled DT to Vero cells. In this case, the experiments were performed at 4°C, a temperature at which only binding is measured since internalization is inhibited at the low temperature. Figure 3A shows the effect of labeled toxin concentration on the level of binding with untreated Vero cells; the specific binding increased as a function of labeled toxin concentration until saturation was achieved at ca. 0.5 ,.g/ml. Figure 3B shows that tunicamycin-treated cells have a markedly reduced level of specific binding; for example, at a toxin concentration of 0.5 ,ug/ml the specific binding was 13% of that observed with untreated Vero cells. It is clear from the results shown in Fig. 3 (27, 28, 30) , that the DT receptor is a cell surface glycoprotein. This conclusion is based on the 50-to 100-fold-decreased sensitivity to DT observed with tunicamycin-treated CHO-Kl cells (Fig. 1) . This decreased sensitivity is not the result of an altered toxin entry process (e.g., alteration in the low-pH-dependent entry into the cytosol from an intracellular vesicle), since acid shock treatment of tunicamycin-treated cells did not restore their toxin sensitivity to the level of that of control cells grown in the absence of tunicamycin (Fig. 2) . This lack of restoration of sensitivity suggested to us (Fig. 3) .
The results presented in this paper are also consistent with the reported decrease in sensitivity observed when toxinsensitive cells are treated with proteases (21, 24 104 receptors per cell) suggests that in tunicamycintreated cells, toxin receptors lacking asparagine-linked oligosaccharides are still translocated to the plasma membrane. Since the toxin binds to these unglycosylated receptors, we can further conclude that the toxin does not bind to the asparagine-linked oligosaccharides. This latter conclusion is consistent with our hypothesis that DT binds to the peptide backbone of the receptor, probably at an anionic region (P' site) (10, 28, 29, 31) . Furthermore, the lack of asparagine-linked oligosaccharides in the toxin receptors of tunicamycin-treated cells probably affects the conformation of the receptor, resulting in a lower affinity (ca. 25-fold) for the toxin and thus in an apparent decrease in functional toxin receptors.
It is quite clear that the receptors for a number of bacterial toxins are carbohydrate-containing macromolecules, either gangliosides or glycoproteins (reviewed in reference 9). The receptors for cholera toxin, Escherichia coli heat-labile toxin, tetanus toxin, and botulinum toxin are believed to be gangliosides, whereas the receptor for Shigella toxin appears to be a glycoprotein (9) . In all of these cases the carbohydrate component is involved in toxin binding (9) . In contrast, as described here, the carbohydrate portion of the glycoprotein DT receptor does not appear to be involved in toxin binding. The receptor for Pseudomonas exotoxin A is known to differ from the receptor for DT (46) . In experiments to be reported elsewhere, we have recently found that tunicamycin-treated CHO-Kl cells are also less sensitive (ca. 10-fold) to Pseudomonas exotoxin A than are untreated cells; interestingly, all the glycosylation-defective CHO-Kl mutants were as sensitive to Pseudomonas exotoxin A as were the parental cell lines (unpublished data). As discussed above for DT, these results suggest that the receptor for Pseudomonas exotoxin A may also be a cell surface glycoprotein.
